$4.3 Billion BRIC Diabetes Care Devices Industry to 2025 - India is Projected to Grow at the Highest CAGR

DUBLIN, July 2, 2020 /PRNewswire/ -- The "Diabetes Care Devices Market by Type (SMBG, CGMS, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes, Mobile Apps), Patient Care Settings (Hospitals & Specialty Clinics, Self & Home Care), and Country (Brazil, Russia, India, China) - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The diabetes care devices (BRIC) market size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period.

The growth in this market is primarily attributed to the sharp increase in diabetes, increasing awareness of diabetes management due to the rising number of diabetes awareness campaigns and screening camps, favorable national health strategies, and government-led endorsement of medical devices.

By type, under the insulin delivery devices segment, insulin pens to hold the largest share during the forecast period

Within the type category, the diabetes care devices (BRIC) market has been segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications. Within the insulin delivery devices segment, insulin pens held the largest share in the market. The increasing affordability of insulin pens, convenience, ease-of-use, and technological advancements in these devices that promote integrated diabetes management support the growth of this segment.

By end-user, the self/ home healthcare segment is expected to grow at a higher rate during the forecast period (2020-2025)

Based on end-user, the diabetes care devices (BRIC) market has been segmented into hospital & specialty clinics and self/home healthcare. The self/home healthcare segment is expected to grow at a higher CAGR due to the increasing awareness of self-management of diabetes, increasing portability of diabetes care devices, and technological innovations that provide real-time insights for patients and healthcare providers for decision-making regarding diabetes control and treatment planning.

India is projected to grow at the highest CAGR

China is expected to account for the largest share of the diabetes care devices (BRIC) market in 2019. The large share of this region can primarily be attributed to the sharp increase in the diabetic population in the past decade and endorsements of medical devices by the government. On the other hand, India is expected to witness the highest CAGR during the forecast period due to the increasing government investment in the medical devices industry, high prevalence of type 1 and gestational diabetes cases, and increasing diabetes awareness creation through campaigns and screening camps.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Diabetes Care Devices Market Overview
4.2 Diabetes Care Devices (Bric) Market: Geographic Growth Opportunities
4.3 Diabetes Care Devices (Bric) Market: Country Mix (2020-2025)

5 Industry Insights
5.1 Industry Trends
5.1.1 Growing Demand for Hybrid Closed-Loop Systems/Artificial Pancreas Device Systems
5.1.2 Smart Glucose Meters Enable Integrated Diabetes Management Solutions
5.1.3 Smart Insulin Pen Synchronization with Glucose Monitoring Systems Promotes Diabetes Data Sharing
5.1.4 Innovative Insulin Delivery Systems
5.2 Regulatory Analysis
5.2.1 China
5.2.2 India
5.2.3 Brazil
5.2.4 Russia
5.3 Covid-19 Impact on the Diabetes Care Devices (Bric) Market

6 Diabetes Care Devices Market, by Type
6.1 Introduction
6.2 Blood Glucose Monitoring Systems
6.2.1 Self-Monitoring Blood Glucose Monitoring Systems
6.2.1.1 Technological Innovations to Drive the Growth of Self-Monitoring Blood Glucose Monitoring Systems
6.2.2 Continuous Glucose Monitoring Systems
6.2.2.1 Increasing Collaborations, Partnerships, and Agreements Between Companies to Develop Integrated Cgm Systems to Drive the Growth of This Market
6.2.3 Test Strips/Test Papers
6.2.3.1 Shift Toward Non-Invasive Methods for Blood Glucose Monitoring to Restrain the Growth of This Market during the Forecast Period
6.2.4 Lancets/Lancing Devices
6.2.4.1 Rising Focus to Reduce the Chances of Infection and Accidental Pricking to Increase the Popularity of Safety Lancets during the Forecast Period
6.3 Insulin Delivery Devices
6.3.1 Insulin Pumps
6.3.1.1 Insulin Pumps Integrated with Continuous Glucose Monitoring Systems Offer the Benefits of Data Integration and Diabetes Management
6.3.2 Insulin Pens
6.3.2.1 the Convenience of Use of Insulin Pens and Increasing Affordability could Drive the Growth of This Segment during the Forecast Period
6.3.3 Insulin Syringes and Needles
6.3.3.1 Safety Concerns and Increasing Awareness of Affordable Alternatives in the Market could Restrain the Growth of This Segment during the Forecast Period
6.4 Diabetes Management Mobile Applications
6.4.1 Growing Adoption of Blood Glucose Tracking Apps and Increasing Awareness of Diabetes Among Patients to Drive Market Growth

7 Diabetes Care Devices Market, by Patient Care Settings
7.1 Introduction
7.2 Self/Home Healthcare
7.2.1 Increasing Affordability of Self-Monitoring Systems and Insulin Delivery Devices Has Fueled the Preference for Self/Home Healthcare
7.3 Hospitals & Diabetes Specialty Clinics
7.3.1 Rising Demand for Poc Testing in Hospitals Boosts the Market Growth

8 Diabetes Care Devices Market in BRIC Countries
8.1 Introduction
8.2 China: Diabetes Care Devices Market
8.2.1 Introduction
8.2.2 Market Drivers
8.2.2.1 Sharp Increase in Diabetes in the Past Decade
8.2.2.2 Favorable National Health Strategies
8.2.2.3 Government-Led Endorsement of the Medical Device Industry
8.2.3 Market Restraints
8.2.3.1 Traditional Chinese Medicine As an Alternative
8.2.3.2 High Cost of Advanced Diabetes Management Devices
8.2.4 Market Opportunities
8.2.4.1 Significant Advancements and Leveraging of Artificial Intelligence and Big Data
8.2.5 Market Challenges
8.2.5.1 Lack of Adherence of Patients to Recommended Diabetes Treatment Guidelines
8.3 India: Diabetes Care Devices Market
8.3.1 Introduction
8.3.2 Market Drivers
8.3.2.1 High Prevalence of Diabetes
8.3.2.2 Government's Make in India Campaign to Encourage Local Manufacturing of Medical Devices
8.3.2.3 Diabetes Awareness Campaigns and Screening Camps
8.3.3 Market Restraints
8.3.3.1 Lack of Accessibility to Healthcare
8.3.3.2 Inadequate Health Insurance Coverage
8.3.4 Market Opportunities
8.3.4.1 Rising Adoption of Mhealth
8.3.5 Market Challenges
8.3.5.1 Shortage of Healthcare Professionals in Diabetes Management
8.4 Brazil: Diabetes Care Devices Market
8.4.1 Introduction
8.4.2 Market Drivers
8.4.2.1 High Prevalence of Diabetes
8.4.2.2 Favorable Government Policies
8.4.3 Market Restraints
8.4.3.1 Lack of Awareness of Diabetes Care
8.4.3.2 High Prices of Advanced Diabetes Care Devices
8.4.4 Market Opportunities
8.4.4.1 Increasing Penetration of Smartphones and Rising Focus on Digital Health to Drive the Growth of Diabetes Management Platforms and Diabetes Management Mobile Applications
8.4.5 Market Challenges
8.4.5.1 Strict Regulatory Guidelines and Regulatory Process for Medical Devices
8.5 Russia: Diabetes Care Devices Market
8.5.1 Introduction
8.5.2 Market Drivers
8.5.2.1 Rising Elderly Population
8.5.2.2 Increasing Rate of Obesity
8.5.3 Market Restraints
8.5.3.1 Large Number of Undiagnosed Diabetics
8.5.4 Market Opportunities
8.5.4.1 Government Spending on Healthcare
8.5.4.2 Rising Investment of Pharma Market Players to Establish Local Manufacturing Plants
8.5.5 Market Challenges
8.5.5.1 Low Adoption of Glucose Monitoring Systems

9 Competitive Landscape
9.1 Overview
9.2 Product Benchmarking
9.3 Geographic Reach of the Top Market Players (2019)
9.4 R&D Expenditure: Key Players in the Diabetes Care Devices (Bric) Market
9.5 Market Share Analysis
9.5.1 Brazil: Diabetes Care Devices Market Share Analysis
9.5.2 Russia: Diabetes Care Devices Market Share Analysis
9.5.3 India: Diabetes Care Devices Market Share Analysis
9.5.4 China: Diabetes Care Devices Market Share Analysis
9.6 Competitive Situation and Trends
9.6.1 Partnerships, Collaborations, and Agreements
9.6.2 Product Approvals, Launches, and Upgrades

10 Company Profiles
10.1 F. Hoffman-La Roche Ltd.
10.2 Abbott
10.3 Ascensia Diabetes Care Holdings Ag
10.4 Dexcom, Inc.
10.5 Medtronic Plc
10.6 B. Braun Melsungen Ag
10.7 Becton, Dickinson and Company
10.8 Acon Laboratories, Inc.
10.9 Arkray, Inc.
10.10 Sanofi
10.11 Novo Nordisk A/S
10.12 Terumo Corporation
10.13 Ypsomed
10.14 Sinocare, Inc.
10.15 Agamatrix Holdings Llc
10.16 Lifescan
10.17 Sd Biosensor, Inc.
10.18 Microgene Diagnostic Systems Pvt. Ltd.
10.19 Dr. Morepen
10.20 Bionime Corporation
10.21 Rossmax International Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/tbnrlb

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets